IBJNews

Biomet files to sell shares in IPO to pay down debt

Back to TopCommentsE-mailPrintBookmark and Share

Indiana-based Biomet Group Inc., a closely held maker of orthopedic medical devices whose shareholders include Blackstone Group LP, filed Friday to sell shares in a U.S. initial public offering to pay down debt.

Biomet, whose owners also include TPG Capital and Goldman Sachs Group Inc., had revenue of more than $3 billion in its latest fiscal year, according to the U.S. regulatory filing. The Warsaw-based company listed $100 million as the possible size of the deal.

The proceeds will be used toward paying debt, the filing said. The company’s net debt was 5.2 times earnings before interest, taxes, depreciation and amortization last year, compared with an average of 0.7 times for larger peers including Stryker Corp., Smith & Nephew Plc and Zimmer Holdings Inc., according to Bloomberg Industries analysts.

Bank of America Corp., Citigroup Inc. and JPMorgan Chase & Co. are among banks managing the IPO, the filing said. Biomet will trade under the symbol BMET.

Biomet reported net income of $36 million for the six months ended Nov. 30, compared with a net loss of $97.7 million a year earlier. Total debt as of Nov. 30 was $5.9 billion.

The company was publicly traded until 2007 when it was acquired by the group of private equity firms under the name LVB Acquisition Inc. The filing said LVB will change its name to Biomet Group Inc. ahead of the IPO’s completion.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
ADVERTISEMENT